Tim Brazelton - Concepedia

Author

Tim Brazelton

Stanford University

Also Known As

T Brazelton, T. Brazelton, T. Brázelton, T. R. Brazelton, T.R. Brazelton, Tim Brazelton, Tim R. Brazelton

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Stanford University Stanford Medicine

About

Tim Brazelton is an author at Stanford University specializing in medicine, transplantation, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	111
2	Immunology	3	3	80
3	Cell Biology	2	2	34
4	Allergy	1	1	10
5	Cellular Therapies	1	1	24

Tim Brazelton

Publications

323

Citations

H-Index

Page 1

	Year	Citations
THE ROLE OF RESPIRATORY EPITHELIUM IN A RAT MODEL OF OBLITERATIVE AIRWAY DISEASE B. Adams, Tim Brazelton, Gerald J. Berry, Transplantation	2000	78
EPITHELIAL RE-GROWTH IS ASSOCIATED WITH INHIBITION OF OBLITERATIVE AIRWAY DISEASE IN ORTHOTOPIC TRACHEAL ALLOGRAFTS IN NON-IMMUNOSUPPRESSED RATS1 Tuija Ikonen, Tim Brazelton, Gerald J. Berry, Transplantation	2000	70
Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo Rajan V. Nair, Xiaobiao Huang, R. Shorthouse, Transplantation Proceedings AsthmaSuperior EfficacyAntiproliferative EffectFibrosisMedicine	1997	46
RAD in stable lung and heart/lung transplant recipients: safety, tolerability, pharmacokinetics, and impact of cystic fibrosis Ramona L. Doyle, Marshall I. Hertz, Jordan Dunitz, The Journal of Heart and Lung Transplantation TransplantationAdvanced Lung DiseaseMedicinePulmonary FibrosisPulmonary Medicine	2001	31
Progression of obliterative airway disease occurs despite the removal of immune reactivity by retransplantation Tim Brazelton, Bridget Adams, Akl Cheung, Transplantation Proceedings	1997	24
Chronic rejection: The result of uncontrolled remodelling of graft tissue by recipient mesenchymal cells? Data from two rodent models and the effects of immunosupressive therapies Tim Brazelton, B. Adams, R. Shorthouse, Inflammation Research Transplant RejectionRegenerative MedicineGraft TissueCell TherapyTransplantation	1999	24
Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus. H. Reichenspurner, V Soni, M. Nitschke, PubMed	1998	21
Developmental stage determines efficiency of gene transfer to muscle satellite cells by in utero delivery of adeno-associated virus vector serotype 2/9 David H. Stitelman, Tim Brazelton, Archana Bora, Molecular Therapy — Methods & Clinical Development	2014	19
Infiltrating recipient mesenchymal cells form the obliterative airway disease lesion and dramatically remodel graft tissue in a model of chronic lung rejection Tim Brazelton, R. Shorthouse, Xiaobiao Huang, Transplantation Proceedings Acute Lung InjuryInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationImmunology	1997	10

Page 1